Saltar al contenido
Merck
Todas las fotos(2)

Documentos

GF05789425

Bismuth

foil, not light tested, 25x25mm, thickness 0.025mm, permanent polyester support, 99.97%

Sinónimos:

Bismuth, BI000160

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(2)

About This Item

Fórmula empírica (notación de Hill):
Bi
Número de CAS:
7440-69-9
Peso molecular:
208.98
MDL number:
MFCD00134033
UNSPSC Code:
12141706
PubChem Substance ID:
329800950
NACRES:
NA.23

vapor pressure

<0.1 mmHg ( 20 °C)

assay

99.97%

form

foil

manufacturer/tradename

Goodfellow 057-894-25

resistivity

129 μΩ-cm, 20°C

size × thickness

25x25 mm × 0.025 mm

bp

1560 °C (lit.)

mp

271 °C (lit.)

density

9.8 g/mL at 25 °C (lit.)

SMILES string

[Bi]

InChI

1S/Bi

InChI key

JCXGWMGPZLAOME-UHFFFAOYSA-N

¿Está buscando productos similares? Visita Guía de comparación de productos

Categorías relacionadas

General description

For updated SDS information please visit www.goodfellow.com.

Legal Information

Product of Goodfellow

Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Jorge A R Salvador et al.
Molecules (Basel, Switzerland), 16(4), 2884-2913 (2011-04-06)
Steroid and terpene chemistry still have a great impact on medicinal chemistry. Therefore, the development of new reactions or "greener" processes in this field is a contemporaneous issue. In this review, the use of bismuth(III) salts, as "ecofriendly" reagents/catalysts, on
Hong Lu et al.
European journal of gastroenterology & hepatology, 25(10), 1134-1140 (2013-06-20)
Antimicrobial resistance has continued to undermine many popular anti-Helicobacter pylori therapies. Antibiotic resistance to commonly used anti-H. pylori drugs in China has increased markedly, making China an ideal site to identify regimens that remain effective despite widespread antimicrobial resistance. Bismuth
P Moayyedi et al.
Alimentary pharmacology & therapeutics, 17(10), 1215-1227 (2003-05-21)
Evidence for the effectiveness of antacids, histamine-2 receptor antagonists, bismuth salts, sucralfate and prokinetic therapy in non-ulcer dyspepsia is conflicting. To conduct a systematic review evaluating these therapies in non-ulcer dyspepsia. Electronic searches were performed using the Cochrane Controlled Trials
Andreia M C Rocha et al.
British journal of haematology, 168(3), 421-428 (2014-09-27)
Helicobacter pylori eradication induces platelet recovery in a subgroup of patients with chronic immune thrombocytopenia (cITP), but the mechanisms involved are still not understood. We aimed to evaluate the effect of H. pylori eradication on platelet response and to identify the
Javier P Gisbert et al.
Helicobacter, 10(3), 157-171 (2005-05-21)
To systematically review the Helicobacter pylori eradication efficacy with ranitidine bismuth citrate (RBC) and two antibiotics, and to conduct a meta-analysis of randomized clinical trials comparing the efficacy of proton pump inhibitor (PPI) vs. RBC with two antibiotics for 1
Ver todos los artículos relacionados

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico